Education
About Us
Working with TipRanks
Follow Us
Essex Bio-Technology (HK:1061)
:1061
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 1.67B | HK$ 1.71B | HK$ 1.32B | HK$ 1.64B | HK$ 978.11M |
| Gross Profit | HK$ 1.50B | HK$ 1.54B | HK$ 1.19B | HK$ 1.40B | HK$ 793.83M |
| Operating Income | HK$ 320.72M | HK$ 310.33M | HK$ 278.05M | HK$ 435.58M | HK$ 237.40M |
| EBITDA | HK$ 400.71M | HK$ 418.38M | HK$ 313.54M | HK$ 436.65M | HK$ 279.50M |
| Net Income | HK$ 307.22M | HK$ 275.26M | HK$ 225.41M | HK$ 345.97M | HK$ 218.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 560.74M | HK$ 515.03M | HK$ 543.49M | HK$ 671.35M | HK$ 599.80M |
| Total Assets | HK$ 2.98B | HK$ 2.83B | HK$ 2.71B | HK$ 2.86B | HK$ 2.42B |
| Total Debt | HK$ 187.04M | HK$ 294.02M | HK$ 489.73M | HK$ 565.19M | HK$ 562.77M |
| Net Debt | HK$ -370.13M | HK$ -215.82M | HK$ -53.75M | HK$ -106.15M | HK$ -37.01M |
| Total Liabilities | HK$ 859.33M | HK$ 903.78M | HK$ 981.03M | HK$ 1.13B | HK$ 995.15M |
| Stockholders' Equity | HK$ 2.12B | HK$ 1.92B | HK$ 1.73B | HK$ 1.73B | HK$ 1.43B |
| Cash Flow | |||||
| Free Cash Flow | HK$ 324.07M | HK$ 211.16M | HK$ 99.87M | HK$ 164.63M | HK$ -18.40M |
| Operating Cash Flow | HK$ 368.47M | HK$ 339.21M | HK$ 382.79M | HK$ 409.16M | HK$ 299.24M |
| Investing Cash Flow | HK$ -106.59M | HK$ -54.34M | HK$ -302.03M | HK$ -280.08M | HK$ -343.27M |
| Financing Cash Flow | HK$ -200.81M | HK$ -309.92M | HK$ -169.11M | HK$ -73.13M | HK$ 149.49M |
Essex Bio-Technology Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.